Glucotrack Receives Nasdaq Delisting Notice
Nasdaq has notified Glucotrack, Inc. that its securities will be delisted following a failure to maintain the minimum bid price requirement.
Stocks · News reference
Glucotrack Announces 1-for-2 Reverse Stock Split
Glucotrack, Inc. is set to implement a 1-for-2 reverse stock split, with trading on a split-adjusted basis beginning October 26, 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Glucotrack, Inc. (GCTK)
Filed: 2026-10-29 AccNo: 0001493152-26-049299 Size: 208 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Glucotrack Subsidiary Lokahi Therapeutics Secures First Fee-for-Service Partnership
Glucotrack, Inc. shares rose following the announcement that its subsidiary, Lōkahi Therapeutics, has entered into its first external, fee-for-service partnership.
GlucoTrack Shares Halted On Circuit Breaker To The Upside, Stock Now Up 86.81%
Glucotrack Issues Senior Secured Convertible Notes
Glucotrack, Inc. has issued $2.56 million in senior secured convertible notes in exchange for $2 million in cash.
Glucotrack Announces 1-For-2 Reverse Stock Split, Effective Oct. 26